If you have advanced or metastatic breast cancer, your doctor might suggest Tykerb as a treatment option. It’s a prescription drug used to treat certain kinds of HER2-positive (HER2+) breast cancer in ...

The active ingredient in Tykerb is lapatinib. (An active ingredient is what makes a drug work.) Tykerb belongs to a group of drugs called tyrosine kinase inhibitors. Tykerb comes as a tablet that you ...

First-line treatment with Tykerb and a taxane failed to improve progression-free survival versus Herceptin plus a taxane in patients with HER2-positive metastatic breast cancer. First-line treatment ...

The decision to withdraw the application was taken after the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) indicated that it is difficult to analyze the risk-benefit properly due to ...

Tykerb comes as an oral tablet. It belongs to a class of drugs known as tyrosine kinase inhibitors. There is currently no generic form of Tykerb available. HER2+ breast cancer that’s HR+ and ...

Findings from one of the largest studies in hormone receptor positive women with first-line oral treatment regimen PHILADELPHIA, Dec. 11 /PRNewswire-USNewswire/ -- New results from a study evaluated ...

GlaxoSmithKline said the FDA has approved its advanced breast cancer treatment Tykerb (lapatinib).Tykerb is developed for use in combination with Roche’s Xeloda for the treatment of patients with ...

Women with persistent and aggressive breast cancer could significantly extend their remaining lifespan by taking GlaxoSmithKline’s Tykerb (lapatinib) in combination with injectable rival Herceptin ...

GlaxoSmithKline's new breast cancer drug Tykerb is to go head-to-head with Genentech's blockbuster Herceptin to see whether one is better or if patients should get both. The U.S. National Cancer ...

The Food and Drug Administration has approved Tykerb, GlaxoSmithKline's new breast cancer pill. The thumbs up not only gives a new option to some cancer patients; it also goes a long way toward ...

Tykerb (lapatinib) is a prescription brand-name medication. It’s approved by the Food and Drug Administration (FDA) to treat some types of HER2-positive (HER2+) breast cancer in adults. HER2 is a ...